Jasper Therapeutics
JSPR
JSPR
58 hedge funds and large institutions have $13.9M invested in Jasper Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12.18% less ownership
Funds ownership: 68.69% → 56.51% (-12%)
61% less capital invested
Capital invested by funds: $35.2M → $13.9M (-$21.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
58
Holding in Top 10
–
Calls
$110K
Puts
$25K
Top Buyers
| 1 | +$1.88M | |
| 2 | +$755K | |
| 3 | +$371K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$106K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$1.9M | |
| 3 | -$1.77M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$888K |
| 5 |
Morgan Stanley
New York
|
-$883K |
